Towa Lines Up More Launches
First-Half Sales Miss Target, But Profit Jumps By Half
Towa has announced plans to launch two new products in December 2019, after the Japanese company reported an increase in sales in its financial first half due to recently-launched products.
You may also be interested in...
Towa says it has lined up four new drugs for launch in June as it has reported annual results that beat company forecasts.
Alvogen’s newly created B2B unit, Adalvo, has partnered with AmbioPharm for the co-development and licensing for the commercialization of several complex pharmaceutical products, including difficult-to-make peptides, in key global markets.
Kodak’s new pharmaceutical unit receives a $765m loan from the US International Development Finance Corporation, through President Trump’s Defense Production Act, to produce critical pharma components that are essential but have lapsed into chronic national shortage, as defined by the FDA.